Want to track GPL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Graft Polymer swoops for Awakn Life Sciences in £5m deal
Graft Polymer (UK) PLC (LSE:GPL) is buying Awakn Life Sciences Corp in an all-paper deal worth £4.98 million, expanding its interest in the fields of mental health and addiction. Awakn, a Canadian clinical-stage biotechnology firm, specialises in treatments for substance use and mental health disorders.
Proactiveinvestors | 1 year ago
Graft Polymer CEO thrilled Awakn Life Sciences partnership progress
Graft Polymer (UK) PLC (LSE:GPL) has reported significant advances in its collaboration with Awakn Life Sciences Corp aimed at developing new therapeutics for trauma-related mental health disorders, including post-traumatic stress disorder (PTSD). Awakn has successfully identified two aminoindane chemical series as lead candidates, marking a crucial step forward in drug development.
Proactiveinvestors | 1 year ago
